SEARCH

SEARCH BY CITATION

References

  • 1
    Yuda S, Fang ZY, Marwick TH: Association of severe coronary stenosis with subclinical left ventricular dysfunction in the absence of infarction. J Am Soc Echocardiogr 2003; 16: 11631170.
  • 2
    Zubelewicz-Szkodzinska B, Szkodzinski J, Romanowski W, Blazelonis A, Danikiewicz A, et al.: Simvastatin decreases concentration of interleukin-2 in hypercholesterolemic patients after treatment for 12 weeks. J Biol Regul Homeost Agents 2004; 18: 295301.
  • 3
    Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, et al.: Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481487.
  • 4
    Kuryata OV, Yeqorova YV: The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis. Kardiol Pol 2006; 64: 4448.
  • 5
    Atalar E, Ozamen F, Hazneedaroglu I, Acil T, Ozer N, et al.: Effects of short-term atorvastatin treatment on global fibrinolytic capacity, and sL-selection and sFas levels in hyperlipidemic patients with coronary artery disease. Int J Cardiol 2002; 84: 227231.
  • 6
    Bountioukos M, Rizzello V, Krenning BJ, Bax JJ, Kertai MD, et al.: Effect of atorvastatin on myocardial contractile reserve assessed by tissue Doppler imaging in moderately hypercholesterolemic patients without heart disease. Am J Cardiol 2003; 92: 613616.
  • 7
    Fujimoto S, Oki T, Tabata T, Tanaka H, Yamada H, et al.: Novel approach to the quantitation of regional left ventricular systolic and diastolic function using tissue Doppler imaging to create a myocardial velocity profile and gradient. Circ J 2003; 67: 416422.
  • 8
    Lee KW, Blann AD, Lip GY: Impaired tissue Doppler diastolic function in patients with coronary artery disease: relationship to endothelial damage/dysfunction and platelet activation. Am Heart J 2005; 150: 756766.
  • 9
    Govind S, Saha S, Brodin LA, Ramesh SS, Arvind SR, et al.: Impaired myocardial functional reserve in hypertension and diabetes mellitus without coronary artery disease: searching for the possible link with congestive heart failure in the Myocardial Doppler in Diabetes (MYDID) Study DD. Am J Hypertens 2006; 19: 851857.
  • 10
    Rowland T, Heffernan K, Jae SY, Echols G, Fernhall B: Tissue Doppler assessment of ventricular function during cycling in 7- to 12-yr-old Boys. Med Sci Sports Exerc 2006; 38: 12161222.
  • 11
    Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, et al.: Implication of recent clinical trials for the national cholesterol education program adult treatment panel DDD guidelines. Circulation 2004; 110: 227239.
  • 12
    Henneman MM, Bax JJ, Schuijf JD, Jukema JW, Holman ER, et al.: Global and regional left ventricular function: a comparison between gated SPECT, 2D echocardiography and multi-slice computed tomography. Eur J Nucl Med Mol Imaging 2006; 33: 14521460.
  • 13
    Oguzhan A, Abaci A, Eryol NK, Topsakal R, Seyfeil E: Colour tissue Doppler echocardiographic evaluation of right ventricular function in patients with right ventricular infarction. Cardiology 2003; 100: 4146.
  • 14
    Koyama J, Ray-Sequin PA, Davidoff R, Falk RH: Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol 2002; 89: 10671071.
  • 15
    Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, et al.: The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 2000; 6: 10041010.
  • 16
    Baller D, Notohamiprodjo G, Gleichmann U, Holzinger J, Weise R, et al.: Improvement in coronary flow reserve determined by positron emission tomography after 6 mo of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation 1999; 99: 28712875.
  • 17
    Huggins GS, Pasternak RC, Alpert NM, Fischman AJ, Gewirtz H: Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reserve. Circulation 1998; 98: 12911296.
  • 18
    Sata M, Nishimatsu H, Suzuki E, Sugiura S, Yoshizumi M, et al.: Endothelial nitric oxide synthase is essential for the HMG-CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia. FASEB J 2001; 15: 25302532.
  • 19
    Pourati I, Kimmelstiel C, Rand W, Karas RH: Statins use is associated with enhanced collateralization of severely diseased coronary arteries. Am Heart J 2003; 146: 876881.
  • 20
    Zoncu S, Pelliccia A, Mercuro G: Assessment of regional systolic and diastolic wall motion velocities in highly trained athletes by pulsed wave Doppler tissue imaging. J Am Soc Echocardiogr 2002; 15: 900905.